News

Bristol-Myers Squibb Company (NYSE: BMY) and Innate Pharma S.A. (Euronext Paris: FR0010331421, IPH) announced a global agreement for the development and commercialization of IPH2102, a novel antibody in Phase I development for the treatment of cancer. ...

Amgen (NASDAQ: AMGN) and UCB (Euronext Brussels: UCB) are collaborating with the National Aeronautics and Space Administration (NASA) Ames Research Center to conduct a preclinical test of a sclerostin antibody in an experiment that will take place aboard space...

An antibody that can fight all types of the influenza A virus has been identified by researchers from the Medical Research Council's National Institute for Medical Research. Studies in fly-infected mice showed that the antibody could...

GlaxoSmithKline and Valeant Pharmaceuticals International, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved Potiga™ (ezogabine) Tablets, a potassium channel opener, as adjunctive treatment of partial-onset seizures in patients aged 18 years and older. ...

Paladin Labs Inc., a leading Canadian specialty pharmaceutical company, today announced that they have entered into a licensing and distribution agreement under which Paladin has been granted exclusive Canadian rights from an affiliate of Elan Corporation,.. ...

Merck appreciates the U.S. Food and Drug Administration's (FDA) recognition of our efforts to create new standardized product packaging for several of our medicines. These changes to the packaging of several medicines were made by Merck...

Forest Laboratories, Inc. announced today that Daliresp(TM) (roflumilast) will be available in pharmacies throughout the United States by mid-June. The U.S. Food and Drug Administration (FDA) recently approved Daliresp as a treatment to reduce the risk...